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ABSTRACT
microRNAs (miRNAs) are abundantly expressed in development where they are critical determi-
nants of cell differentiation and phenotype. Accordingly miRNAs are essential for normal skele-
tal development and chondrogenesis in particular. However, the question of which miRNAs are
specific to the chondrocyte phenotype has not been fully addressed. Using microarray analysis
of miRNA expression during mesenchymal stem cell chondrogenic differentiation and detailed
examination of the role of essential differentiation factors, such as SOX9, TGF-b, and the cell
condensation phase, we characterize the repertoire of specific miRNAs involved in chondrocyte
development, highlighting in particular miR-140 and miR-455. Further with the use of mRNA
microarray data we integrate miRNA expression and mRNA expression during chondrogenesis to
underline the particular importance of miR-140, especially the -5p strand. We provide a detailed
identification and validation of direct targets of miR-140-5p in both chondrogenesis and adult
chondrocytes with the use of microarray and 30UTR analysis. This emphasizes the diverse array
of targets and pathways regulated by miR-140-5p. We are also able to confirm previous experi-
mentally identified targets but, additionally, identify a novel positive regulation of the Wnt sig-
naling pathway by miR-140-5p. Wnt signaling has a complex role in chondrogenesis and skeletal
development and these findings illustrate a previously unidentified role for miR-140-5p in regu-
lation of Wnt signaling in these processes. Together these developments further highlight the
role of miRNAs during chondrogenesis to improve our understanding of chondrocyte develop-
ment and guide cartilage tissue engineering. STEM CELLS 2015; 00:000–000
SIGNIFICANCE STATEMENT
miRNAs are small genes that have emerged as critical regulators of cell behaviour and differen-
tiation. Here we have used a model of cartilage development from stem cells (chondrogenesis)
to identify all miRNA and gene changes during the process. By manipulating this chondrogene-
sis we are able to define the key miRNAs associated with the cartilage phenotype. Correlating
gene and miRNA expression data we identify the particular importance of the -5p strand of
miR-140 during chondrogenesis, which we confirm with additional experiments. These develop-
ments will enhance our understanding of cartilage tissue engineering, a process with potential
as therapy for the treatment of osteoarthritis or focal cartilage defects.
INTRODUCTION
Cartilage is found at the end of bones in articu-
lating joints where it provides both a structural
role to resist compression and a lubricating
function for low friction movement. Chondro-
cytes are solely capable of producing cartilage
extracellular matrix (ECM) which is largely com-
posed of collagen for structural integrity and
proteoglycan for water adsorption. During
development chondrocytes also lay the scaffold
for long bone formation by terminally differen-
tiating and undergoing hypertrophy to allow
resorption and ossification, characteristic of
bone formation [1].
In vivo, chondrocytes develop from undif-
ferentiated mesenchymal stem cells (MSCs) in
limbs to form cartilage anlage. Cells aggregate
to form high density condensations which pro-
vide cell-cell contacts required for initiating
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the chondrogenic process [1]. Essential for this process is the
transcription factor SOX9 which in combination with extracel-
lular cues promotes the expression of ECM genes such as the
type II collagen characteristic of cartilage [2]. This capacity of
MSCs is used in vitro, where a similar process driven by TGF-
b leads to formation of a cartilaginous disc in well defined
high density cultures or supported scaffold structures [3, 4].
Such preparations are potential sources of material in clinical
applications to replace damaged or defective cartilage. In par-
ticular, sufferers of osteoarthritis (OA), an age-related degen-
erative joint disease, experience significant cartilage
destruction which might be amenable to replacement by in
vitro preparations of autologous MSC-derived cartilage [5].
Greater understanding of the mechanisms involved in dif-
ferentiation aids development of viable tissue for tissue engi-
neering applications. microRNAs (miRNAs), which control gene
expression post-transcriptionally, are abundantly expressed in
development where they are critical determinants of cell dif-
ferentiation and phenotype [6]. miRNAs are small single-
stranded noncoding RNAs which base-pair with complemen-
tary mRNA targets to elicit transcript repression [7]. miRNAs
are generally processed from Pol-II-derived pri-miRNA tran-
scripts, initially by Drosha in the nucleus then Dicer cyto-
plasmically, to form a mature miRNA which is subsequently
incorporated into the Argonaute containing RNA-induced
silencing complex (RISC) [8]. The miRNA seed sequence, nucle-
otides 2–7, forms the major mRNA recognition determinant
leading to target mRNA translation repression and transcript
cleavage by RISC [7].miRNAs are essential for normal skeletal
development. Mice with a chondrocyte-specific deletion of
Dicer exhibit severe bone growth defects typified by a reduc-
tion in growth plate chondrocyte proliferation and increased
hypertrophy [9]. A number of miRNAs have been proposed to
play important roles in chondrogenesis, in particular miR-140
and miR-455 appear to follow a chondrocyte restricted
expression profile during development, and miR-140 is directly
regulated by SOX9 [10–14]. miR-140 is upregulated during
MSC differentiation into chondrocytes and plays a role in car-
tilage development and maintenance [11, 15]. miR-140 null
mice exhibit a skeletal phenotype with long bone growth
retardation again indicative of reduced chondrocyte prolifera-
tion [11, 16]. Significantly, the miR-140 null mice also develop
articular cartilage damage with age and are more susceptible
to surgically induced OA, potentially due to increased
Adamts5 levels, a target of miR-140 [11]. However, the effect
of miR-140 on Adamts5 is modest and a number of other tar-
gets of miR-140 have been proposed, including Dnpep, Hdac4,
IGFBP5, and Smad3 [10, 16–18]. As a result, miR-140 is pro-
posed to modulate a number of cell pathways and functions
including platelet-derived growth factor (PDGF) signaling via
the PDGF receptor, and cell proliferation via Sp1 [14, 19].
We sought to establish a comprehensive picture of miRNA
expression and target regulation in chondrogenesis by inte-
grating miRNA and mRNA expression data. We then further
established the requirement for specific differentiation factors,
including SOX9, TGF-b, and cell condensation, in chondrogene-
sis miRNA expression. This analysis ultimately indicated that
the -5p strand of miR-140-5p is particularly critical in the reg-
ulation of chondrocyte gene expression. Consequently we
identified and validated a number of novel targets of
miR-140-5p in both adult articular chondrocytes and during
chondrogenesis. This highlighted the diverse range of miR-
140-5p targets and also indicated a previously unidentified
role for miR-140 in Wnt signaling.
MATERIALS AND METHODS
Human Bone Marrow Stem Cell Culture
Human bone marrow MSCs (from seven donors, 18–25 years
of age) were isolated from human bone marrow mononuclear
cells (Lonza Biosciences, Berkshire, U.K.) by adherence for
more than 24 hours to tissue culture plastic and were
expanded in monolayer culture in mesenchymal stem cell
growth medium (Lonza Biosciences) supplemented with 5 ng/
ml fibroblast growth factor-2 (R&D Systems, Abingdon, U.K.).
Cultures were maintained in a humid atmosphere of 5% CO2/
95% air at 378C. Once cells reached confluence, they were
passaged (P1) using Trypsin/EDTA at a split ratio of 1:3.
Experiments were performed using cells between P2 and P7,
and all experiments were repeated with cells from three to
four donors. The phenotypes of all donors of MSCs were
tested by flow cytometry on a FACSCanto II system (Becton
Dickinson, Oxford, U.K.) using a human MSC Phenotyping Kit
(Miltenyi Biotec, Bisley, U.K.) with positive staining for CD73,
CD90, and CD105 and negative staining for CD14, CD20,
CD34, and CD45 (three of which can be found in the supple-
mentary material of reference [20]). Cells were also demon-
strated to be capable of differentiation into osteoblastic and
adipogenic lineages (Supporting Information Fig. S1 and Sup-
porting Information Materials and Methods).
Chondrogenic Differentiation
MSCs were resuspended in chondrogenic culture medium
consisting of high glucose Dulbecco’s modified Eagle’s medium
containing 100 mg/ml sodium pyruvate (Lonza), 10 ng/ml TGF-
b3 (PeproTech, London, U.K.), 100 nM dexamethasone, 13
ITS-1 premix, 40 mg/ml proline, and 25 mg/ml ascorbate-2-
phosphate (all from Sigma-Aldrich, Poole, U.K.). 5 3 105 MSC
in 100 ml medium were pipetted onto 6.5 mm diameter, 0.4-
mm pore size polycarbonate Transwell filters (Merck Millipore,
Watford, U.K.), centrifuged in a 24-well plate (200g, 5
minutes), then 0.5 ml of chondrogenic medium was added to
the lower well as described [3]. Media were replaced every 2
or 3 days up to 14 days.
Immunohistochemistry and Histology
Transwell discs were fixed in ethanol and processed into par-
affin wax. Sections cut at 4 mm were either stained with hae-
matoxylin and eosin or Safranin O/Fast Green (all Sigma), or
probed with antibodies raised against collagen type II (Abcam,
Cambridge, U.K.). Sections were digested with 1% hyaluroni-
dase for 30 minutes at 378C and incubated at 48C overnight
with primary antibodies at an appropriate dilution in block
solution. After sequential incubation with biotinylated second-
ary antibody signal was detected with the Vectastain Elite
ABC Kit (Vector Laboratories, Peterborough, U.K.) following
the manufacturer’s instructions and developed using diamino-
benzidine (Sigma-Aldrich). Images were collected using a Zeiss
Axioplan 2 (Cambridge, U.K.).
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Chondrocyte Isolation and Culture
Primary human articular chondrocytes (HAC) were derived
from articular cartilage obtained from joint replacement
patients (from nine donors, 58–80 years of age; Supporting
Information Materials and Methods) diagnosed with OA. All
tissues were obtained with informed consent and ethics com-
mittee approval from the Newcastle and North Tyneside
Health Authority. Enzymatic digestion of tissue and mainte-
nance and culture of cells were as previously described [21].
When cells reached confluence they were passaged into the
appropriate experimentation vessel. Human chondrosarcoma
cells (SW1353) were cultured as described [22].
RNA and miRNA Extraction and Real-Time Reverse
Transcription PCR
Total RNA was isolated from cultured HAC for array expression
profiling using Qiagen miRNeasy kit (Qiagen, Crawley, U.K.)
following the manufacturer’s instructions, and for real-time
RT-PCR with Ambion Cells-to-cDNA II kit (Life Technologies,
Paisley, U.K.). Three-dimensional MSC cartilage discs were dis-
rupted in mirVana miRNA Isolation Kit Phenol (for array
expression profiling) or TRIzol (for real-time RT-PCR) (both Life
Technologies) using a small disposable plastic pestle and an
aliquot of Molecular Grinding Resin (G-Biosciences, St. Louis,
MO). Total RNA was converted to cDNA using Invitrogen
MMLV reverse transcriptase (Life Technologies) and TaqMan
RT-PCR was performed and gene expression levels calculated
as described previously [23]. Primer sequences and assay
details can be found in Supporting Information Materials. For
universal miRNA reverse transcription total RNA was con-
verted to cDNA using NCode miRNA First-Strand cDNA Synthe-
sis Kit (Life Technologies) following the manufacturer’s
instructions. Real-time PCR was performed with Invitrogen
Platinum SYBR Green qPCR SuperMix (Life Technologies) and
miRNA-specific primers (Supporting Information Materials).
For single miRNA-specific analysis, RNA was reverse-
transcribed with Applied Biosystems TaqMan MicroRNA
Reverse Transcription Kit (Life Technologies) and real-time RT-
PCR performed with TaqMan MicroRNA assays (Life Technolo-
gies). All values are presented as the mean6 SEM of repli-
cates in pooled experiments. For experiments with multiple
MSC donors statistical testing was performed using a matched
paired two-tailed Student’s t test on log-transformed values
to account for non-normal distribution.
Gene/miRNA Expression Profiling and Analysis
Illumina whole-genome expression array Human HT-12 V4
(Illumina, Saffron Walden, U.K.) was used to profile gene
expression of RNA samples according to the manufacturer’s
protocol. For miR-140-5p target identification in HAC duplicate
biological samples for each treatment were assessed. For MSC
chondrogenesis gene expression triplicate biological samples
for Days 0 and 14 were assessed, and single biological sam-
ples for intermediate time points. Raw expression data were
analyzed using Agilent GeneSpring GX 11 (Agilent Technolo-
gies, Santa Clara, CA). Raw data were normalized with a quan-
tile algorithm and the baseline was transformed to the
median of all samples. Exiqon 6th generation miRCURY LNA
microRNA Array (Exiqon, Vedbaek, Denmark) was used to pro-
file miRNA expression of RNA samples according to the manu-
facturer’s protocol. Duplicate biological samples for each time
point in MSC chondrogenesis were assessed. Normalization of
the quantified signals (background corrected) was performed
using the global Lowess regression algorithm. Expression anal-
ysis was performed in R/bioconductor using the limma pack-
age [24]. Differentially expressed gene lists were ranked
according to their fold changes and compared with sets of
genes that were classified according to the gene ontologies
for molecular function, cellular component, and biological pro-
cess. Sylamer analyses were carried out to determine the
enrichment of seed matches among the genes upregulated or
downregulated during MSC chondrogenesis or following
experimental manipulation of miR-140-5p levels [25]. DREM
(Dynamic Regulatory Event Miner) version 2.0 is software that
analyzes time course expression data and additional data on
interactions of transcriptional regulators with the genes, using
an Input-Output Hidden Markov Model [26]. We have
extended DREM to add miRNAs as possible gene regulators
using data from TargetScan, and applied the miRNA regulation
data to a combined time course of both miRNA and gene
expression [27]. A minimum log 2-fold-change of 1 was
applied, and genes with no regulator information were
retained in the analysis. The train-test method was used for
model selection and bifurcations of gene groups (but not
higher order splits) were used when fitting the model.
RNA-Mediated Interference and miRNA
Mimic/Inhibitor Transfection in MSC and HAC
For siRNA transfection, 100 nM siRNA was transfected into
40%–50% confluent MSC using Dharmacon Dharmafect 1 lipid
reagent (Thermo Fisher Scientific, St. Leon-Rot, Germany).
Dharmacon siRNA SMARTpools (Thermo Fisher Scientific) of
four specific siRNA duplexes (total of 100 nM siRNA) were
used to target SOX9 (M-021507) and DICER1 (M-003483).
Depletion of gene-specific mRNA levels was calculated by
comparison of expression levels with cells transfected with
100 nM siCONTROL (nontargeting siRNA 2, cat. 001210-02;
Dharmacon). For modulation of miR-140-5p levels in MSC and
HAC, Dharmacon miRIDIAN mimics (C-300607), miRIDIAN hair-
pin inhibitors (IH-300607), or miRCURY LNA microRNA Power
Inhibitors (with phosphorothioate bonds only in the extrem-
ities to avoid toxicity) (Exiqon) were transfected by the same
method as above (all 100 nM). Analysis was performed in
comparison with Dharmacon miRIDIAN miRNA mimic nontar-
geting Control #2 (CN-002000-01), Sigma-Aldrich MISSION
nontargeting miRNA control 2 (HMC0003), Dharmacon miRI-
DIAN miRNA hairpin inhibitor nontargeting Control #2 (IN-
002005-01), or miRCURY LNA miRNA Power Inhibitor negative
control B as indicated (all 100 nM). For all experiments, cells
were subject to only a single transfection, either prior to
induction of MSC differentiation or for the indicated time
period in MSC and HAC.
Cloning and Plasmid Transfection in SW1353 Cells
Full length miRNA target 30UTRs were amplified from human
genomic DNA using PCR primers (Supporting Information
Materials) to enable Clontech In-Fusion HD cloning (Takara
Bio Europe, Saint-Germain-en-Laye, France) into the pmirGLO
Dual-Luciferase miRNA Target Expression Vector (Promega,
Southampton, U.K.) following the manufacturer’s instructions.
Mutation of the miRNA seed-binding sites was performed
Barter, Tselepi, Gomez et al. 3
www.StemCells.com VC 2015 The Authors. STEM CELLS Published by
Wiley Periodicals, Inc. on behalf of AlphaMed Press
using the QuikChange II Site-Directed Mutagenesis Kit (Agilent
Technologies). All vectors and mutations were sequence veri-
fied. SW1353 chondrosarcoma cells were plated overnight in
96-well plates at 50% confluence (18,000 cells per square cen-
timeter). Cells were first transfected with 30UTR luciferase
constructs (10 ng) using FuGENE HD transfection reagent
(Promega) for 4 hours then transfected with Dharmacon miR-
140-5p mimic (50 nM) or miRNA mimic nontargeting Control
#2 using Dharmafect 1. After 24 hours of transfection, the
SW1353 cells were washed and lysed using Reporter Lysis
Buffer (Promega) and firefly and renilla luciferase levels deter-
mined using the Promega Dual-Luciferase Reporter Assay Sys-
tem and a GloMax 96 Microplate Luminometer (Promega).
The TOPFlash construct contains T cell factor (TCF) binding
upstream of a luciferase reporter gene and is widely used to
assess b-catenin-dependent signaling [28]. FOPFlash contains
mutated TCF binding sites and is used as a negative control.
TOPFlash and FOPFlash reporter luciferase plasmids in combi-
nation with miRNA mimic were transfected for 24 hours as
above then cells were stimulated with recombinant Wnt3a
(R&D Systems) for 24 hours before lysis. All values are pre-
sented as the mean6 SD of replicates in pooled experiments.
Significant differences between sample groups were assessed
by one-way analysis of variance followed by the Bonferroni
post hoc test for multiple comparisons or a two-tailed Stu-
dents t test was performed for single comparisons.
Immunoblotting
Lysates from MSCs or SW1353 cells were prepared as
described previously [23]. Cytoplasmic and nuclear fractions
were isolated using the NE-PER Extraction Kit (Thermo Fisher
Scientific). Lysates or fractions were immunoblotted with the
following antibodies: b-catenin and Lamin A/C (Cell Signaling
Technology), and GAPDH (Millipore). Secondary anti-rabbit
antibodies were from Dako (Ely, U.K.) and chemi-luminescent
images were captured using a G:BOX Chemi system (Syngene,
Cambridge, U.K.).
RESULTS
MSCs were cultured in chondrogenic differentiation medium
for 14 days in Transwell hanging cell culture inserts. A flexible,
translucent cartilage-like disc is formed (Fig. 1A) which exhib-
its homogeneous distribution of matrix components such as
sulphated GAG and type II collagen (Fig. 1B). Gene expression
for a number of cartilage ECM components and transcription
factors indicates a robust differentiation (Fig. 1C), as has pre-
viously been described [3]. This chondrogenic differentiation is
highly reproducible between different MSC donors (Support-
ing Information Fig. S2).
We used siRNA targeting the DICER1 gene to investigate
the role of Dicer-dependent miRNAs during chondrogenesis.
Depletion of DICER1 (Fig. 1D) disrupted formation of the
cartilage-like disc early in the 14 day differentiation process
(Fig. 1E). Induction of miRNAs such as miR-140-5p was abro-
gated by the loss of DICER (Fig. 1F). This was accompanied by
a failure of the cells to effectively upregulate gene expression
of selected cartilage components to the level of nontargeting
siRNA (Fig. 1G), together indicating that miRNAs are essential
for the process of chondrogenic differentiation.
In order to establish which miRNAs might regulate chon-
drogenesis we profiled the expression of miRNAs during MSC
chondrogenic differentiation by Exiqon microarray. Of the
1,048 miRNAs measured, 51 were significantly upregulated
greater than twofold during the 14 days time course, and 12
downregulated (Fig. 2A, Supporting Information Table S1). The
regulation of a number of the most upregulated and downre-
gulated miRNAs was validated by qRT-PCR in additional MSC
donors (Fig. 2B). We previously profiled miRNA expression
during mouse ATDC5 chondrogenesis [12] and of the miRNAs
common to both human and mouse, 12 were upregulated in
both MSC and ATDC5 chondrogenesis suggesting association
with the chondrocyte phenotype (Fig. 2C). Four were downre-
gulated in both models.
To further establish which miRNAs are central to chondro-
cyte biology we assessed their dependence on chondrogenic
factors including SOX9, TGF-b, and cell condensation. Deple-
tion of SOX9 by siRNA (Fig. 3A) prevented formation of the
cartilage-like disc during differentiation (Fig. 3B) and upregula-
tion of cartilage gene expression (Fig. 3C). Expression of
chondrocyte-restricted miRNAs miR-140 and miR-455 was
markedly reduced in the absence of SOX9 (Fig. 3D). Induction
of a number of other miRNAs was also diminished following
depletion of SOX9, including miRs 181a-5p, 148a-3p, 152, and
23c. Removal of TGF-b3 or culturing of cells at low density
during differentiation also inhibits chondrogenic disc forma-
tion (Fig. 3E) and gene expression (Fig. 3F). Similarly miR-140
and miR-455 induction are particularly dependent on these
factors and to a lesser extent a number of other miRNAs (Fig.
3G). In contrast, the expression of a number of miRNAs was
independent of TGF-b (miRs 210, 199b-5p, 26a, and 195-5p)
or condensation (miRs 152, 199b-5p, and 23c).
Following our characterization of the chondrogenic miRNA
repertoire we sought to identify potential targets for these
miRNAs. We profiled gene expression changes in the same
MSC chondrogenic differentiation time course samples by
microarray and identified more than 2,000 genes that were
significantly regulated greater than twofold (Fig. 4A, Support-
ing Information Table S2). Further to our validation of chon-
drocyte gene expression (Fig. 1C), examination of gene sets
upregulated during chondrogenesis by global gene ontology
analysis indicated significant enrichment for ECM and skeletal
system development reflecting known hallmarks of chondro-
genesis (Supporting Information Table S3). Sylamer is an
unbiased method for detecting overrepresented miRNA tar-
gets in ranked gene expression data [25]. Sylamer analysis of
the chondrogenic expression data revealed significant enrich-
ment of 7-mer miR-140-5p seed sequences among the down-
regulated genes suggesting that miR-140, specifically miR-140-
5p, has the most impact of any miRNA on gene expression
during chondrogenesis (Fig. 4B). Additionally, we modified
DREM software to analyze time course expression data using
miRNAs as possible gene regulators using data from TargetS-
can 3 [26, 27]. We found that only expression of miR-140-5p
targets predicted by TargetScan and assessed by DREM were
more likely to be downregulated during the initial phase of
chondrogenesis compared with targets of unchanged miRNAs
(Fig. 4C).
Our data indicate that miR-140-5p is the predominant
miRNA strand regulating chondrogenesis. We reasoned target
identification would be most successful in adult chondrocytes
4 miR-140-5p Targets in MSC Chondrogenesis
VC 2015 The Authors. STEM CELLS Published by STEM CELLS
Wiley Periodicals, Inc. on behalf of AlphaMed Press
which express the highest levels of miR-140-5p (ENCODE/
CSHL small RNA-seq. and unpublished data) rather than on
the dynamic transcriptome background of differentiating
MSCs [29]. Accordingly, we used microarray analysis to iden-
tify candidate genes regulated by miR-140-5p in human adult
chondrocytes from articular cartilage (HAC). We over-
expressed and inhibited miR-140-5p (Fig. 5A) and identified
genes that were upregulated or downregulated in comparison
with nontargeting control treatment (Fig. 5B, Supporting Infor-
mation Table S4). Sylamer analyses revealed significant
enrichment of 7-mer miR-140-5p seed sequences among the
regulated genes (Fig. 5C). Pathway analysis highlighted that
many of the miR-140-5p targets were found in lysosomes and
membranes (Supporting Information Table S5). We selected
candidate genes based on greatest repression by miR-140-5p
mimic or greatest upregulation after miR-140-5p inhibition
and validated many of these by real-time qRT-PCR in addi-
tional HAC populations (Fig. 5D, 5E). Consistent with the
array, many transcripts are targeted by miR-140-5p with
GALNTL1 the most susceptible to overexpression of miR-140-
Figure 1. MicroRNA processing machinery is essential for chondrogenesis. (A): Mesenchymal stem cells (MSCs) were cultured in chon-
drogenic differentiation medium for 14 days in hanging transwell inserts to form a cartilaginous disc. (B): Day 14 chondrogenic discs
were fixed, sectioned, and stained with H&E, safranin O (GAG), or anti-collagen II antibody. (C): RNA was extracted from MSCs under-
going chondrogenic differentiation at the indicated time points between Day 0 and Day 14, and expression of the indicated genes meas-
ured by real-time RT-PCR. (D–G): MSCs were transfected for 3 days with DICER1-targeting or nontargeting control siRNA prior to
chondrogenic differentiation for 3 days in hanging transwell inserts. RNA was extracted at Days 0 and 3, and the indicated gene expres-
sion assessed by real-time RT-PCR. (D): DICER1 expression at Day 0 normalized to 18S. (E): Day 3 chondrogenic discs overlaid on trans-
well membrane. (F): miR-140-5p expression normalized to U6. (G): Day 3 chondrogenesis gene expression normalized to 18S. (A), (B),
(C), and (E) are representative of experiments performed in four MSC donors. Values in (D), (F), and (G) are the mean6 SEM of data
pooled from four separate MSC donors. *, p< .01; ***, p< .001 for DICER1 siRNA versus nontargeting siRNA for each gene per time
point. Abbreviation: H&E, hematoxylin and eosin.
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5p, while FZD6 and B3GNT1 were upregulated most by inhibi-
tion of miR-140-5p and therefore the predominant targets of
endogenous miR-140-5p. To assess which of these candidate
genes are directly targeted by miR-140-5p, we cloned the 30
untranslated regions (30UTRs) of the most regulated candi-
dates for luciferase assays. We confirmed many as bona fide
targets of miR-140-5p by mutation of 30UTR target sites
including FZD6, GALC, GALNTL1, MMD, and RALA (Fig. 5E).
Having established the chondrocyte targets of miR-140-5p,
we then sought to confirm these targets during the altering
phenotype of MSCs undergoing chondrogenesis and increasing
miR-140-5p levels. Examination of the expression of these
miR-140-5p targets in our MSC chondrogenesis mRNA array
indicated that the majority are downregulated during chon-
drocyte development (Fig. 6A). To directly examine whether
miR-140-5p regulates these genes during chondrogenesis we
inhibited miR-140-5p in MSCs prior to chondrogenic differen-
tiation. Inhibition of miR-140-5p (Fig. 6B) had no observable
effect on cartilage disc formation (Fig. 6C) or wet mass (data
not shown). However, the expression of specific cartilage
genes COL2A1 and ACAN was significantly reduced at Day 14
(Fig. 6D). With a pellet model of chondrogenesis we observed
a modest, but not significant, reduction in cartilage GAG lev-
els at earlier time points following miR-140-5p inhibition (Sup-
porting Information Fig. S3). A number of identified targets,
including RALA, B3GNT1, and GALC, were derepressed follow-
ing inhibition of miR-140-5p indicating that their downregula-
tion during chondrogenesis is a function of miR-140-5p
activity (Fig. 6E). RALA has been recently implicated as a tar-
get of miR-140 and may function in regulation of SOX9 levels
[30]. In contrast, GALNTL1 and ADAMTS5 expressions were
not derepressed following inhibition of miR-140-5p.
FZD6 emerged as a predominant target of miR-140-5p at
the transcript level and in 30UTR luciferase studies (Fig. 5E,
5G). During chondrogenesis, FZD6 is downregulated in a miR-
140-5p-dependent manner (Fig. 7A). FZD6 is a receptor for
the Wnt signaling pathway which may direct signaling via the
noncanonical pathway [31, 32]. miRNAs are increasingly pro-
posed to regulate targets in pathways and consistent with
this we found additional transcripts associated with the Wnt
pathway were regulated by miR-140-5p including AIDA,
TAX1BP3, OSTM1, GPR177, and FZD9 (Fig. 5B) [33–37]. Fur-
thermore, miR-140-5p upregulated the expression of Wnt-
responsive gene Wnt1-induced signaling protein 1 (WISP1)
(Fig. 7B). Using a well-established Wnt-inducible luciferase
reporter we found that miR-140-5p promoted the activation
of the Wnt pathway (Fig. 7C). This was not mediated through
an increase in cellular b-catenin levels (Fig. 7D) or nuclear
translocation of b-catenin (Fig. 7E) in MSCs or SW1353 cells.
Figure 2. Profile of miRNA expression during chondrogenesis.
MSCs were cultured in chondrogenic differentiation medium for
14 days in hanging transwell inserts to form a cartilaginous disc.
RNA was extracted at the indicated time points between Day 0
and Day 14. (A): Heatmap representation of more than twofold
significantly regulated miRNA expression assessed by microarray
from one MSC donor. (B): Expression of selected miRNAs in data
pooled three from MSC donors by real-time RT-PCR. (C): Venn
diagram of common miRNAs regulated in human MSC and mouse
ATDC5 chondrogenesis. miRNAs in red or blue are upregulated or
downregulated, respectively, in both models of chondrogenesis.
Abbreviation: MSC, mesenchymal stem cell.
6 miR-140-5p Targets in MSC Chondrogenesis
VC 2015 The Authors. STEM CELLS Published by STEM CELLS
Wiley Periodicals, Inc. on behalf of AlphaMed Press
Figure 3. Requirement for SOX9, TGF-b, and high density in chondrogenic miRNA expression. (A–D): Mesenchymal stem cells (MSCs)
were transfected for 3 days with SOX9-targeting or nontargeting control siRNA prior to chondrogenic differentiation for 7 days in hang-
ing transwell inserts. RNA was extracted at Days 0, 3, and 7, and the indicated gene expression assessed by real-time RT-PCR. (A): SOX9
expression normalized to 18S. (B): Day 3 chondrogenesis disc overlaid on transwell membrane. (C): Days 3 and 7 chondrogenesis gene
expression normalized to 18S. (D): Days 3 and 7 chondrogenesis miRNA expression following SOX9 depletion. Expression is normalized
to U6 and presented as a percentage of nontargeting control levels. (E–H): MSCs were cultured in chondrogenic differentiation medium
with or without TGF-b3 for 7 days in hanging transwell inserts to form a cartilaginous disc or in monolayer at low cell density. (E): Day
3 chondrogenesis disc overlaid on transwell membrane. (F): Days 3 and 7 chondrogenesis gene expression normalized to 18S. (G, H):
Days 3 and 7 chondrogenesis miRNA expression following (G) TGF-b3 removal or (H) monolayer culture. Expression is normalized to U6
and presented as a percentage of control levels. Values are the mean6 SEM of data pooled from three separate MSC donors. *,
p< .05; **, p< .01; ***, p< .001 for (A–D) SOX9 siRNA versus nontargeting siRNA or (E–H) the specified treatment versus control for
each gene or miRNA per time point.
In addition, there was no induction of other classic Wnt-
responsive genes such as AXIN2 (Fig. 7G).
DISCUSSION
With the use of a well-defined efficient chondrogenesis
model, we have presented the first integrated analysis of
gene expression and miRNA expression during chondrocyte
development. By modulating elements of the differentiation
we have assessed the expression requirements of miRNAs
during chondrogenesis to establish a fully characterized chon-
drocyte repertoire of miRNAs. Overwhelmingly the predomi-
nant miRNA operator during chondrogenesis was miR-140 and
for the first time we provide evidence that the miR-140-5p
strand is likely to mediate the majority of miR-140 effects.
Consistent with other studies, we demonstrate the require-
ment for miR-140-5p in chondrocyte development but addi-
tionally we expand considerably the experimentally verified
targets for miR-140-5p in chondrocytes and additionally con-
firm their regulation by miR-140-5p during chondrogenesis. A
number of targets have links with Wnt pathways and as a
result we identify a previously unappreciated role for miR-
140-5p in promoting Wnt signaling.
Previous studies have sought to identify miRNA expression
changes in models of chondrogenesis [12, 38, 39]. We used
an optimized model of chondrogenesis in transwells which is
characterized by rapid differentiation and uniform distribution
of a cartilage-like matrix [3]. This was evidenced by significant
upregulation of gene expression and matrix molecule staining.
Dicer, and by association miRNAs, is essential for chondrocyte
proliferation and maintenance of the prehypertrophic state [9,
40]. Severe skeletal defects result from loss of Dicer in chon-
drocytes in mice. Dicer and miRNAs appear similarly essential
for our in vitro chondrogenesis system whereby its depletion
results in failure of cartilage disc formation and incomplete
upregulation of the chondrocyte gene expression program.
The miRNA processing machinery is similarly required for dif-
ferentiation of MSCs into osteoblast and adipocyte lineages
suggesting that proper levels of mature miRNAs are essential
for stem cell differentiation [41].
We identified a number of miRNAs regulated during chon-
drogenesis, the majority upregulated. Many of the
Figure 4. Profile of mRNA expression during chondrogenesis.
Mesenchymal stem cells (MSCs) were cultured in chondrogenic dif-
ferentiation medium for 14 days in hanging transwell inserts to
form a cartilaginous disc. RNA was extracted at the indicated time
points between Day 0 and Day 14 and assessed by microarray for
one MSC donor. (A): Heatmap and hierarchical clustering represen-
tation of top 50 gene expression changes assessed by microarray.
(B): Sylamer analysis performed on the sorted gene list of expres-
sion changes at Day 14 compared to Day 0. Shown are Sylamer
enrichment landscape plots for seven nt sequence words. The blue
line represents miR-140-5p seed (AACCACT) match sites. (C):
Dynamic regulatory event miner (DREM) analysis of microarray
time course data of genes and miRNAs. The lines connect the
medians of groups of regulated genes. The green nodes are those
nodes where a set of genes, jointly upregulated or downregulated
until that time, split. The size of the node is proportional to the SD
of the expression change of set of genes passing through that
node. miRs shown in blue are themselves upregulated in that seg-
ment of the time course. Only the miRs with the predicted highest
confidence (p 5 3 1026) are shown.
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Figure 5. mRNA targets of miR-140-5p in chondrocytes. (A–C): HAC were transfected for 48 hours with miR-140-5p mimic (mi) or hair-
pin (hp) inhibitor, or nontargeting controls. RNA was extracted and gene expression assessed by microarray for one HAC donor. (A):
miR-140-5p expression normalized to U6. (B): Heatmap of top 25 genes downregulated by miR-140-5p mimic and top 25 upregulated
by miR-140-5p hairpin inhibitor ordered by difference between mimic and inhibitor expression levels. (C): Sylamer analysis performed
on the ordered gene list of expression changes after miR-140-5p mimic or inhibitor treatment compared to nontargeting control. Shown
are Sylamer enrichment landscape plots for seven nt sequence words. The colored lines represent miR-140-5p seed match sites. (D, E):
HAC were transfected for 48 hours with miR-140-5p mimic (mi) or power inhibitor (pi), or nontargeting control miRNA mimic or power
inhibitor. Expression of selected genes following miR-140-5p (D) mimic or (E) inhibitor treatment by real-time RT-PCR. The ACAN gene is
not a target of miR-140-5p and therefore acted as control. Expression is normalized to 18S and presented as fold change compared to
nontargeting control levels. Values are the mean6 SEM of data pooled from four separate HAC donors with each experiment performed
in hextuplicate. (F): Luciferase expression in SW1353 cells following cotransfection of miR-140-5p target 30UTR reporter constructs and
miR-140-5p mimic or nontargeting control mimic for 24 hours. Expression is normalized to renilla luciferase and presented as a percent-
age of control levels. Values are the mean6 SD of data pooled from two to six independent experiments. *, p< .05; **, p< .01; ***,
p< .001 for each gene-specific 30UTR versus empty pmiRGLO plasmid. #, p< .05; ##, p< .01 for the indicated gene-specific 30UTR versus
mutant gene-specific 30UTR. Abbreviation: HAC, human articular chondrocytes.
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upregulated miRNAs are consistent with our previous study of
chondrogenesis in mouse ATDC5 cells supportive of their role
during chondrogenesis. Specifically both -5p and -3p strands
of cartilage-restricted miR-140 and miR-455 are highly ele-
vated during MSC chondrogenesis [10, 12]. A number of other
miRNAs already associated with chondrocyte function are also
upregulated including miR-148a and miR-199 [42, 43].
However, comparison with miRNAs upregulated during MSC
differentiation into other lineages suggests that some miRNAs
are associated with differentiation per se rather than
chondrogenesis specifically. For example, miRs-23, -26, -199a,
and -152 are also upregulated during either or both MSC
osteogenesis or adipogenesis [41]. miR-1246 and miR-1290
are upregulated at a later stage in chondrogenesis but recent
Figure 6. Effect of modulation of miR-140-5p levels on chondrogenesis, chondrocyte gene expression, and miR-140-5p target genes.
(A): Heatmap of mesenchymal stem cell (MSC) chondrogenesis gene expression of the previously identified human articular chondro-
cytes top 50 miR-140-5p targets. (B–E): MSCs were transfected for 3 days with the indicated miR-140-5p inhibitors or nontargeting con-
trol inhibitors prior to chondrogenic differentiation for 14 days in hanging transwell inserts. RNA was extracted at Days 0, 7, and 14,
and the indicated gene expression assessed by real-time RT-PCR. (B): miR-140-5p expression normalized to 18S. (C): Day 14 chondro-
genic discs overlaid on transwell membrane. Representative of experiments performed in four MSC donors. (D): Day 14 chondrogenesis
gene expression normalized to 18S. (E): Gene expression of selected experimentally verified miR-140-5p targets normalized to 18S. Pre-
sented as fold change compared to nontargeting control levels. Values are the mean6 SEM of data pooled from three to four separate
MSC donors. *, p< .05; **, p< .01; ***, p< .001 for miR-140-5p inhibitor versus nontargeting inhibitor.
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evidence suggests that miR-1246 is a pseudo-miRNA nuclear
fragment of the longer U2 small nuclear RNA [44], and miR-
1290 is almost an exact 12 frameshift sequence of miR-1246
and assay detection may not differentiate between the two.
To establish which of the regulated miRNAs are more spe-
cific to chondrogenesis, rather than MSC differentiation, we
removed critical aspects of the chondrogenic program includ-
ing SOX9, TGF-b, and high density [45]. SOX9 is the master
transcription factor in chondrogenesis regulating the expres-
sion of cartilage ECM genes [46]. TGF-b is required for post-
translational modifications and synergistic enhancement of
chondrocyte gene expression with SOX9 [47], while high cell
density mimics the in vivo cellular condensation phase of
chondrogenesis [45]. SOX9, in combination with SOX5 and
SOX6, initiates miR-140 expression during chondrogenesis and
in chondrocyte populations. Specifically the miR-140 locus
proximal promoter houses SOX9 binding sites within 3 kb of
the transcription start site [13, 14]. We demonstrate here that
cartilage-restricted miR-455 also has a similar requirement for
SOX9. The mature miR-455 miRNAs originate from a hairpin
encoded within intron 10 of the COL27A1 gene [12]. In con-
trast to the miR-140 locus consensus sequence searches fail
to identify any potential proximal SOX9 binding sites around
the miR-455 locus. Expression of COL27A1 itself is regulated
by SOX9 responsive elements in intron 1 [48]. The upregula-
tion of miR-455 parallels the kinetics of COL27A1 expression
and thus it seems likely the increase in miR-455 levels are a
consequence of COL27A1 induction [12, 49]. Other miRNAs
have a varying requirement for SOX9 however the significant
impact of loss of SOX9 on MSC chondrogenesis disrupts all
gene expression at later time points. The absence of high cell
density almost completely abolished the induction of matrix
genes and chondrocyte-restricted miR-140 and miR-455. miR-
181 also emerged as particularly dependent on these funda-
mental factors in chondrogenesis. miR-181 has an established
role as both effector and regulator of the TGF-b signaling
pathway [50–54], but previous studies indicate a role in pro-
moting osteoblastogenesis and repressing cartilage gene
expression [55–57]. In contrast, the upregulation of miR-199
is unaffected by loss of SOX9, TGF-beta, or cell-cell contacts,
Figure 7. Effect of miR-140-5p on the Wnt signaling pathway. (A): MSCs were transfected for 3 days with miR-140-5p inhibitor or non-
targeting control inhibitor prior to chondrogenic differentiation for 14 days in hanging transwell inserts. RNA was extracted at Days 0, 7,
and 14, and FZD6 gene expression assessed by real-time RT-PCR. Presented as fold change compared to nontargeting control levels. **,
p< .01 for miR-140-5p inhibitor versus nontargeting inhibitor. (B): MSC, human articular chondrocytes (HAC), or SW1353 cells were
transfected with miR-140-5p mimic (mi) or nontargeting control miRNA mimic for 48 hours. WISP1 gene expression normalized to 18S.
(C): Luciferase expression in SW1353 cells following cotransfection of TOPFlash/FOPFlash Wnt reporter constructs and miR-140-5p mimic
or nontargeting control mimic for 24 hours 1/2 Wnt3a (100 ng/ml) stimulation for 24 hours. Expression is normalized to renilla lucifer-
ase and presented as fold change compared to nontargeting control levels. Values are the mean6 SD of data pooled from three inde-
pendent experiments. *, p< .05 for miR-140-5p inhibitor versus nontargeting inhibitor. (D): MSCs were transfected with miR-140-5p
mimic or nontargeting control miRNA mimic for 24 hours 1/2 Wnt3a (100 ng/ml) stimulation for 24 hours. Whole cell protein was
extracted and the indicated proteins measured by immunoblotting. (E): SW1353 cells were transfected with miR-140-5p mimic or non-
targeting control miRNA mimic for 24 hours. Cytoplasmic and nuclear protein fractions were extracted for immunoblotting. Anti-Lamin
and anti-GAPDH antibodies were used to confirm nuclear and cytoplasmic fractionation, respectively. (F): Quantification of b-catenin
immunoblot whole cell and nuclear levels in four MSC donors and three independent SW1353 cell experiments. (G): AXIN2 expression
after 48 hours normalized to 18S as for (B). For real-time PCR, values are the mean6 SEM of data pooled from three to four separate
MSC or HAC donors, or three independent experiments in SW1353 cells. Abbreviation: MSC, mesenchymal stem cell.
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perhaps consistent with its upregulation in differentiation of
MSCs into other lineages [41]. Accordingly, we suggest only
miR-140 and miR-455 as chondrogenesis-specific miRNAs,
with miR-181 and miR-148 also appearing intrinsically linked
to the chondrogenic program.
Having characterized the chondrocyte miRNA profile we
integrated analysis of chondrogenesis gene expression
changes to establish the functional miRNAs during chondro-
cyte development. Application of an unbiased miRNA target
site enrichment analysis by Sylamer revealed significant
enrichment of miR-140-5p seed sequences above and beyond
any other miRNA in the downregulated genes during chondro-
genesis [25]. The applicability of this analysis was verified by
our modulation of miR-140-5p levels in HAC which identified
a great enrichment of seed-match-containing mRNAs, consist-
ent with the notion that functional miRNA modulation leads
to regulation of direct targets. In addition, using an a priori
knowledge approach with predicted miRNA binding sites from
TargetScan DREM also highlighted the enrichment of miR-140-
5p targets in genes downregulated during chondrogenesis.
Taken together, these data suggest that miR-140-5p is the pre-
dominant miRNA acting during chondrogenesis. This is consist-
ent with a recent study with mice with both miR-140
deficiency and Lin28a overexpression, to inhibit let-7 miRNAs,
indicating that the Dicer null skeletal phenotype might be
largely attributable to loss of these miRNAs only [58]. Murine
miR-140 knockouts lack both -5p and -3p strands of miR-140
as the whole locus is disrupted meaning the phenotype is
unable to be pinned on the loss of one strand in particular
[11, 16]. However, in vitro studies have confirmed the major-
ity of targets for the -5p strand of miR-140 in chondrocytes
and MSCs (Supporting Information Table S6). Interestingly, this
apparent dominance of miR-140-5p occurs despite the cellular
miR-140-3p levels exceeding those of miR-140-5p in both
adult chondrocytes and MSC chondrogenesis (ENCODE/CSHL
small RNA-seq. and data not shown) [29]. It is possible that
miR-140-3p may significantly regulate only a few targets and
thus its importance would not be recognized by target enrich-
ment analyses such as Sylamer. However, the prevailing view
of miRNA function supports the suppression of multiple tar-
gets with regulation often only twofold or less [59].
Most studies focus on the role of miRs during chondro-
genesis without reference to the impact in primary chondro-
cytes. Our identification of the potential role of the -5p
strand of miR-140 prompted us to establish the targets of
miR-140-5p in HAC, cells from the tissue exhibiting highest
expression of miR-140 in adult humans (ENCODE/CSHL small
RNA-seq.) [29]. Inhibition of miR-140-5p allowed us to identify
targets of the endogenous miRNA, the ideal method for indi-
cating targets in vivo, while over-expression of miR-140-5p
suggested transcripts which might become targets if levels of
the miRNA increase in disease as has previously reported for
miR-140-5p in OA [12]. Importantly, our data indicate that,
owing to the very high endogenous levels of miR-140, as little
as a twofold change significantly impacts on the abundance
of many target mRNAs. Luciferase assays confirmed many of
these as direct targets, adding significantly to the number of
already validated targets. Additionally, we have now validated
that IGFBP5 is a direct target of miR-140-5p and repeated the
findings identifying MMD and RALA as targets [17, 30, 60].
Previously identified targets in mouse, for example, ADAMTS5,
HDAC4, and DNPEP, appear to be species-specific targets of
miR-140-5p as we found no regulation in human chondrocytes
[10, 11, 16]. In addition, targets of miR-140-5p identified in
other cell types or tissues do not appear to be regulated in
chondrocytes, for example, mitofusin 1 and TGFBRI [61–65].
With reference to the change in miR-140 levels in OA, 16 of
our top 50 miR-140-5p targets identified in HAC are altered in
OA (Supporting Information Table S7) which raises the possi-
bility that these disease-associated alterations might be a con-
sequence of miRNA expression changes [66, 67]. A study
correlating levels of miR-140-5p and its targets in OA patients
and healthy controls would help address this question.
Strikingly, almost all our experimentally identified targets of
miR-140-5p were downregulated during MSC chondrogenesis
and inhibition of miR-140-5p during chondrogenesis indicated
that miR-140-5p directly contributed to this downregulation.
This suggests that miR-140-5p targets similar genes during
chondrogenesis and in differentiated adult articular chondro-
cytes. Although it is clear miR-140-5p regulates multiple targets
in seemingly disparate pathways, we were interested to note
that FZD6 emerged as a major target from mRNA and 30UTR
studies. FZD6 has been identified as a negative regulator of the
canonical Wnt signaling pathway by virtue of its inhibition of
TCF/lymphoid enhancer-binding factor (LEF) transcription factor
transactivation [31], and may promote a Wnt4 mediated beta-
catenin-independent pathway [32]. FZD6 was downregulated
during chondrogenesis and has been found upregulated during
osteogenic differentiation, consistent with the antagonistic
roles of SOX9 and RUNX2 in promoting their respective pro-
grams of differentiation [68]. miR-140-5p also appears to
repress osteogenesis in contrast to its role promoting chondro-
cyte development [69]. Exploring the potential of miR-140-5p
to regulate the Wnt pathway we observed upregulation of TCF/
LEF reporter activity and induction of WISP1 expression, a Wnt-
induced gene [70]. Such activation of Wnt signaling is consist-
ent with a reduction in FZD6 levels and therefore loss of its
negative regulation on canonical Wnt signaling. However, FZD6
levels correlate with beta-catenin activation in MSCs [71] and
disruption of the receptor reduces response to Wnt3a and lev-
els of Wnts [72]. Consistent with these contradictory mecha-
nisms we see regulation of canonical reporter and target genes
but not on canonical b-catenin and AXIN gene levels. Interest-
ingly, a b-catenin-independent activation of TOPFlash involving
ATF2 has been reported [73]. Using an RNAi approach we were
unable to demonstrate a direct role for loss of FZD6 in media-
ting the upregulation of Wnt signaling by miR-140-5p (data not
shown). In fact, a number of our top 50 targets of miR-140-5p
have putative links with the Wnt signaling pathway including
AIDA, TAX1BP3 (TIP1), OSTM1, GPR177, and FZD9 [33–37].
OSTM1 has already been demonstrated to be a direct target of
miR-140-5p but its role in Wnt signaling in this report was not
explored [74]. Thus, our data suggest that miR-140-5p may reg-
ulate Wnt signaling via one of these identified targets.
The role of Wnt signaling in chondrocytes and skeletal
development is complex and sometimes contradictory [75].
Overexpression studies have indicated that Wnt3a and a num-
ber of other Wnt family members inhibit chondrogenesis from
the condensation phase through a b-catenin-dependent
mechanism [75, 76]. The role of b-catenin then switches after
chondrocyte development and activation is required for the
later hypertrophic maturation of chondrocytes. However, a
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couple of studies contradict these and suggest that Wnt3a, b-
catenin, and LEF may promote SOX9 expression and as a
result chondrogenesis [77]. Our data suggest that miR-140-5p
might be able to activate TCF/LEF-dependent gene expression
while avoiding the negative effects of activating b-catenin dur-
ing chondrogenesis. miR-140-5p also upregulated expression
of WISP1, a member of the CCN protein family, which is
expressed in limb development, specifically in condensing
mesenchyme, during chondrocyte terminal differentiation and
in bone formation sites [70]. Interestingly, WISP1 promotes
proliferation of MSCs and prechondrocytes and miR-140-5p
has previously been posited to contribute to chondrocyte pro-
liferation [58, 70]. Our pathway analysis on genes upregulated
following overexpression of miR-140-5p indicated cell cycle
regulation by miR-140-5p, and the upregulation of WISP1 and
the activation of Wnt signaling, which has an established role
in cell cycle progression and cell proliferation, also contribute
to a potential for miR-140 to promote MSC and chondrocyte
proliferation.
We also over-expressed miR-140-5p in MSCs prior to chon-
drogenic differentiation in order to address the question of
whether increased miR-140-5p levels could enhance chondro-
cyte development. Contrary to expectation, the over-expression
of miR-140-5p impaired cartilage formation and chondrocyte
gene expression (Supporting Information Fig. S4). Such immedi-
ate over-expression may have inhibited the early stages of
chondrogenesis where MSCs usually experience a more con-
trolled increase in miR-140-5p levels to repress unwanted tar-
gets during differentiation. Similarly we used an RNAi approach
to repress miR-140-5p targets RALA and FZD6 prior to chondro-
genesis to determine whether their depletion would enhance
chondrogenesis. Again, we found that this approach unexpect-
edly reduced chondrocyte differentiation (data not shown). As
a result we would suggest that for engineering approaches
seeking to improve chondrocyte differentiation and cartilage
formation an inducible mechanism of over-expression of miR-
NAs or repression of targets would be more appropriate in
order to mimic the natural order of events.
Taken together, our data confirm that miR-140-5p is an
essential regulator of chondrocyte gene expression, and estab-
lish that miR-140-5p actually regulates multiple targets to
elicit its effect in chondrocyte development and function,
including contributing to the impact of the Wnt signaling
pathway. Owing to the regulation of these targets in both
MSCs and HAC, the significant induction of miR-140 during
MSC chondrogenesis, and it being the most abundant miRNA
in adult chondrocytes, we believe miR-140-5p has an equally
important role in both regulating targets during MSC chondro-
genesis and then maintaining the suppression of these targets
in adult chondrocytes (HAC) to maintain the chondrocyte
phenotype.
CONCLUSIONS
We have characterized the miRNAs regulated during chondro-
genesis and highlighted those most specific to the chondro-
cyte phenotype. Integrating miRNA and mRNA expression
data allowed us to identify the -5p strand of miR-140 as the
primary miRNA regulating gene expression during chondro-
genesis. Consistent with other miRNAs we have validated mul-
tiple targets of miR-140-5p, and in particular we identify its
regulation of Wnt signaling, an essential pathway involved in
skeletal development.
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